Pierluigi Bove

Rome, 00133, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 155 publications

Molecular Evaluation of RNA-Based Immune Checkpoint Profiling in Clear Cell Renal Cell Carcinoma.

Molecular Evaluation of RNA-Based Immune Checkpoint Profiling in Clear Cell Renal Cell Carcinoma.

Journal: Journal of clinical medicine

Published: April 10, 2026

Plasma metabolomic profiling identifies a metabolic signature for non-muscle-invasive bladder cancer independent of hematuria.

Plasma metabolomic profiling identifies a metabolic signature for non-muscle-invasive bladder cancer independent of hematuria.

Journal: Biology direct

Published: March 06, 2026

The Italian Society of Urology Statement on focal therapy for localized prostate cancer.

The Italian Society of Urology Statement on focal therapy for localized prostate cancer.

Journal: Minerva urology and nephrology

Published: February 16, 2026

Glycosaminoglycans and hyaluronic acid in chronic prostatitis/primary prostate pain syndrome: an evidence-grounded perspective.

Glycosaminoglycans and hyaluronic acid in chronic prostatitis/primary prostate pain syndrome: an evidence-grounded perspective.

Journal: Frontiers in surgery

Published: November 24, 2025

Accuracy of cognitive vs software-guided MRI-targeted biopsy in predicting final grading at prostatectomy.

Accuracy of cognitive vs software-guided MRI-targeted biopsy in predicting final grading at prostatectomy.

Journal: BJU international

Published: October 23, 2025

Short-term results of curcumin, quercetin, hyaluronic acid and chondroitin sulfate (Ialuril Soft Gels®) in the management of chronic prostatitis/primary prostate pain syndrome: a single-center prospective study.

Short-term results of curcumin, quercetin, hyaluronic acid and chondroitin sulfate (Ialuril Soft Gels®) in the management of chronic prostatitis/primary prostate pain syndrome: a single-center prospective study.

Journal: Frontiers in surgery

Published: September 07, 2025

Sexual safety and efficacy of a pollen extract and teupolioside-based supplement in men with benign prostatic hyperplasia: a prospective observational study.

Sexual safety and efficacy of a pollen extract and teupolioside-based supplement in men with benign prostatic hyperplasia: a prospective observational study.

Journal: Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica

Published: September 06, 2025

Thulium laser incision of prostate with selective median lobe vaporesection versus water vapor thermal therapy in the treatment of benign prostatic obstruction with ejaculation-sparing intent: a retrospective, comparative analysis from two institutions.

Thulium laser incision of prostate with selective median lobe vaporesection versus water vapor thermal therapy in the treatment of benign prostatic obstruction with ejaculation-sparing intent: a retrospective, comparative analysis from two institutions.

Journal: International urology and nephrology

Published: August 13, 2025

Defining the optimal duration of maintenance mitomycin C in intermediate-risk Ta NMIBC: a multicenter retrospective landmark analysis.

Defining the optimal duration of maintenance mitomycin C in intermediate-risk Ta NMIBC: a multicenter retrospective landmark analysis.

Journal: International urology and nephrology

Published: August 05, 2025

Real-World Burden and Management of Late Genitourinary Toxicity After Prostate Radiotherapy: Insights from IRRADIaTE, the Italian Registry of Radiotherapy-Associated Disorders and Urological Treatment & Evaluation.

Real-World Burden and Management of Late Genitourinary Toxicity After Prostate Radiotherapy: Insights from IRRADIaTE, the Italian Registry of Radiotherapy-Associated Disorders and Urological Treatment & Evaluation.

Journal: European urology oncology

Published: July 30, 2025

Enhanced prognostic value of four-tier hybrid grading system in Ta non-muscle-invasive bladder cancer.

Enhanced prognostic value of four-tier hybrid grading system in Ta non-muscle-invasive bladder cancer.

Journal: BJU international

Published: June 25, 2025

Development and Validation of the PREVES-HOR Questionnaire: A Patient-Reported Measure of Hormone Therapy-Related Quality of Life in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy.

Development and Validation of the PREVES-HOR Questionnaire: A Patient-Reported Measure of Hormone Therapy-Related Quality of Life in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy.

Journal: Oncology

Published: May 30, 2025

Showing 1-12 of 155

Last Updated: 09/26/2026